Single-cell focus Target immunotherapy and engineered cell therapy researchers who need high-resolution single-cell analysis and rapid screening capabilities enabled by Xdrop double-emulsion droplets for accurate cell potency and heterogeneity assessments.

High-throughput potential Position Xdrop Sort as a scalable microfluidics solution for high-throughput screening, enabling faster discovery cycles in gene and cell screening, which appeals to biotechs seeking efficiency and speed at scale.

Workflow integration Leverage your tech stack and cloud infrastructure partnerships to offer integrated data and analysis workflows (flow cytometry compatibility, data management, and cloud-based analytics) that fit existing customer IT ecosystems.

Service and access Promote comprehensive service programs and CRISPR validation services to labs seeking access to Xdrop capabilities without large in-house investment, aligning with Samplix’s history of enabling labs through services.

Strategic partnerships Explore collaborations with established CROs, biotech accelerators, and gene/editing tool providers to broaden market reach, leveraging Samplix’s accelerator-backed development efforts and prior industry collaborations.